AstraZeneca $27B wipeout as Wainua late trial misses cardiovascular target
A failed late-stage heart study triggered a swift market punishment, forcing investors and boards to reset timelines and risk.

Curating from trusted global sources…
76 briefings · “ring”
A failed late-stage heart study triggered a swift market punishment, forcing investors and boards to reset timelines and risk.

Stokes announces retirement from international cricket during the ongoing third Test, reshaping leadership and selection decisions for England.

SpaceX exercised its option for Cursor in an all-stock deal worth $60 billion, reshaping AI dealmaking expectations.

New York turns 37 first-half points into an identity-defining defensive second half, winning their first title in 53 years.

Enterprises lose top-tier Claude access overnight, with fallback models auto-routing and an uncertain path to restoration.

The largest IPO in history gives Elon Musk's rocket company a win, and signals how massive the next OpenAI and Anthropic deals could be.

A 20% first-day pop pushes Musk past a 13-digit milestone and forces markets to reprice space risk.

First-day trading for the aerospace and AI company turned an unprecedented IPO into a $2tn-style market reckoning for public-market readiness.

SpaceX shares jumped, and Musk’s $800B pre-IPO value crossed a trillion, reshaping how investors price “moonshots.”

The IPO priced at $135, surged on Nasdaq and Texas, and immediately rewired how executives think about mega-debuts.
Forced buyers and tracker funds could amplify buying pressure as SpaceX joins the Nasdaq index on a rule tweak.

The SPCX listing breaks records, but Japanese household investors quietly took a meaningful chunk of the biggest payday ever.